QLGN will change its name to AIxCrypto after the shareholders' meeting on November 12th, and plans to increase the size of its crypto treasury to $50 million.

According to Odaily Planet Daily, Nasdaq-listed Qualigen Therapeutics (QLGN) announced that it will change its name to AIxCrypto after the shareholders' meeting on November 12. The company plans to achieve three major milestones by the end of 2025:

1. Expand C10 Treasury’s assets under management to US$50 million

2. Accelerate the global growth of BesTrade DeAI Agent

3. List Crypto Ecosystem Token on leading exchanges